The Pyrrolidinoindoline Alkaloid Psm2 Inhibits Platelet Aggregation and Thrombus Formation by Affecting PI3K/Akt Signaling

Overview

Journal Acta Pharmacol Sin

Specialty Pharmacology

Date 2016 Jul 19

PMID 27424653

Citations 16

Authors

Xing-Li Su

Wen Su

Ying Wang

Yue-Hu Wang

Xin Ming

Yi Kong

Affiliations

Soon will be listed here.

Abstract

Aim: Psm2, one of the pyrrolidinoindoline alkaloids isolated from whole Selaginella moellendorffii plants, has shown a potent antiplatelet activity. In this study, we further evaluated the antiplatelet effects of Psm2, and elucidated the underlying mechanisms.

Methods: Human platelet aggregation in vitro and rat platelet aggregation ex vivo were investigated. Agonist-induced platelet aggregation was measured using a light transmission aggregometer. The antithrombotic effects of Psm2 were evaluated in arteriovenous shunt thrombosis model in rats. To elucidate the mechanisms underlying the antiplatelet activity of Psm2, ELISAs, Western blotting and molecular docking were performed. The bleeding risk of Psm2 administration was assessed in a mouse tail cutting model, and the cytotoxicity of Psm2 was measured with MTT assay in EA.hy926 cells.

Results: Psm2 dose-dependently inhibited human platelet aggregation induced by ADP, U4619, thrombin and collagen with IC50 values of 0.64, 0.37, 0.35 and 0.87 mg/mL, respectively. Psm2 (1, 3, 10 mg/kg) administered to rats significantly inhibited platelet aggregation ex vivo induced by ADP. Psm2 (1, 3, 10 mg/mL, iv) administered to rats with the A-V shunt dose-dependently decreased the thrombus formation. Psm2 inhibited platelet adhesion to fibrinogen and collagen with IC50 values of 84.5 and 96.5 mg/mL, respectively, but did not affect the binding of fibrinogen to GPIIb/IIIa. Furthermore, Psm2 inhibited AktSer473 phosphorylation, but did not affect MAPK signaling and Src kinase activation. Molecular docking showed that Psm2 bound to phosphatidylinositol 3-kinase β (PI3Kβ) with a binding free energy of -13.265 kcal/mol. In addition, Psm2 did not cause toxicity in EA.hy926 cells and produced only slight bleeding in a mouse tail cutting model.

Conclusion: Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling. Psm2 may be a lead compound or drug candidate that could be developed for the prevention or treatment of thrombotic diseases.

Citing Articles

Network pharmacology analysis and clinical verification of saponins in deep venous thrombosis prevention.

Yan B, Ning Y, Guo J, Liu L, Wang C Biomed Rep. 2024; 22(1):8.

PMID: 39559819 PMC: 11572032. DOI: 10.3892/br.2024.1886.

Clinical significance and underlying mechanism of long non-coding RNA SNHG12 in lower extremity deep venous thrombosis.

Xiao S, Wang C, Li Y, Zhang K, Jiao X, Zhao Z Clin Transl Sci. 2024; 17(10):e70023.

PMID: 39396235 PMC: 11471149. DOI: 10.1111/cts.70023.

Marine-Fungus-Derived Natural Compound 4-Hydroxyphenylacetic Acid Induces Autophagy to Exert Antithrombotic Effects in Zebrafish.

Xin S, Zhang M, Li P, Wang L, Zhang X, Zhang S Mar Drugs. 2024; 22(4).

PMID: 38667765 PMC: 11051058. DOI: 10.3390/md22040148.

Astragaloside IV induces endothelial progenitor cell angiogenesis in deep venous thrombosis through inactivation of PI3K/AKT signaling.

Lyu X, Yi Z, He Y, Zhang C, Zhu P, Liu C Histol Histopathol. 2024; 39(9):1149-1157.

PMID: 38275076 DOI: 10.14670/HH-18-704.

Deep sequencing of circulating miRNAs and target mRNAs level in deep venous thrombosis patients.

Wang Q, Chang Y, Yang X, Han Z IET Syst Biol. 2023; 17(4):212-227.

PMID: 37466160 PMC: 10439493. DOI: 10.1049/syb2.12071.

References

Savage B, Saldivar E, Ruggeri Z . Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996; 84(2):289-97. DOI: 10.1016/s0092-8674(00)80983-6. View

Johnson S . Known knowns and known unknowns: risks associated with combination antithrombotic therapy. Thromb Res. 2008; 123 Suppl 1:S7-11. DOI: 10.1016/j.thromres.2008.08.011. View

Ma D, Xu X, An S, Liu H, Yang X, Andersen J . A novel family of RGD-containing disintegrins (Tablysin-15) from the salivary gland of the horsefly Tabanus yao targets αIIbβ3 or αVβ3 and inhibits platelet aggregation and angiogenesis. Thromb Haemost. 2011; 105(6):1032-45. PMC: 3499621. DOI: 10.1160/TH11-01-0029. View

Gao C, Boylan B, Bougie D, Gill J, Birenbaum J, Newman D . Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain. J Clin Invest. 2009; 119(3):504-11. PMC: 2648674. DOI: 10.1172/JCI36745. View

Chen M, Ye X, Ming X, Chen Y, Wang Y, Su X . A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates. Sci Rep. 2015; 5:10846. PMC: 4451689. DOI: 10.1038/srep10846. View

Jackson S, Schoenwaelder S, Goncalves I, Nesbitt W, Yap C, Wright C . PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med. 2005; 11(5):507-14. DOI: 10.1038/nm1232. View

Yang T, Jia M, Mei Q, Shang P . [Effects of Angelica polysaccharide on blood coagulation and platelet aggregation]. Zhong Yao Cai. 2003; 25(5):344-5. View

Wang Y, Long C, Yang F, Wang X, Sun Q, Wang H . Pyrrolidinoindoline alkaloids from Selaginella moellendorfii. J Nat Prod. 2009; 72(6):1151-4. DOI: 10.1021/np9001515. View

Klafke J, da Silva M, Rossato M, Trevisan G, Walker C, Leal C . Antiplatelet, Antithrombotic, and Fibrinolytic Activities of Campomanesia xanthocarpa. Evid Based Complement Alternat Med. 2011; 2012:954748. PMC: 3170703. DOI: 10.1155/2012/954748. View

10.

Huang Z, Zeng C, Zhu L, Jiang L, Li N, Hu H . Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase. J Thromb Haemost. 2010; 8(6):1383-93. DOI: 10.1111/j.1538-7836.2010.03859.x. View

11.

Kong Y, Wang Y, Yang W, Xie Z, Li Z . LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa. J Pharmacol Sci. 2015; 127(4):462-6. DOI: 10.1016/j.jphs.2015.03.010. View

12.

Chadderdon R, Cappello M . The hookworm platelet inhibitor: functional blockade of integrins GPIIb/IIIa (alphaIIbbeta3) and GPIa/IIa (alpha2beta1) inhibits platelet aggregation and adhesion in vitro. J Infect Dis. 1999; 179(5):1235-41. DOI: 10.1086/314724. View

13.

Sheu J, Hung W, Wu C, Lee Y, Yen M . Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in in vivo experiments. Br J Haematol. 2000; 110(1):110-5. DOI: 10.1046/j.1365-2141.2000.01953.x. View

14.

Da Silva M, Lucena S, Aguilar I, Rodriguez-Acosta A, Salazar A, Sanchez E . Anti-platelet effect of cumanastatin 1, a disintegrin isolated from venom of South American Crotalus rattlesnake. Thromb Res. 2008; 123(5):731-9. DOI: 10.1016/j.thromres.2008.08.001. View

15.

Michelson A . Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov. 2010; 9(2):154-69. DOI: 10.1038/nrd2957. View

16.

Pan C, Wei X, Ye J, Liu G, Zhang S, Zhang Y . BF066, a novel dual target antiplatelet agent without significant bleeding. PLoS One. 2012; 7(7):e40451. PMC: 3398006. DOI: 10.1371/journal.pone.0040451. View

17.

Umetsu T, Sanai K . Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats. Thromb Haemost. 1978; 39(1):74-83. View

18.

Hyun K, Jeong S, Lee D, Park J, Lee J . Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides. 2005; 27(6):1173-8. DOI: 10.1016/j.peptides.2005.10.005. View

19.

Huang J, Wang S, Luo X, Xie Y, Shi X . Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents. Thromb Res. 2006; 119(3):337-42. DOI: 10.1016/j.thromres.2006.03.001. View

20.

Jackson S, Yap C, Anderson K . Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans. 2004; 32(Pt 2):387-92. DOI: 10.1042/bst0320387. View